US Patent Issued to NEC on Nov. 25 for "Peptide based vaccine generation system with dual projection generative adversarial networks" (New Jersey Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,482,534, issued on Nov. 25, was assigned to NEC Corp. (Tokyo).

"Peptide based vaccine generation system with dual projection generative adversarial networks" was invented by Renqiang Min (Princeton, N.J.), Hans Peter Graf (South Amboy, N.J.) and Ligong Han (Edison, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method generates new binding peptides to Major Histocompatibility Complex (MHC) proteins. The method includes training, a Generative Adversarial Network (GAN) having a generator and a discriminator only on a set of binding peptide sequences given training data comprising the set of binding peptide sequences and a set of non-binding peptide...